Save time and get answers to complex questions with AI chat
Zemdri nce gain exclusivity 2028 patent 2031?Is guselkumab off patent in u s?Dabrafenib patent expiration date novartis gsk composition matter?Drugpatentwatch skyrizi biologic patent analysis?Sun pharma bortezomib?
See the DrugPatentWatch profile for Fasenra
The information needed to give a specific annual price for Fasenra in 2025 or 2026 depends on the country, the exact product pricing (usually list price), and whether you mean cost for a typical patient on the standard dosing schedule. The provided materials here do not include Fasenra’s 2025/2026 annual pricing. If you tell me your country (and whether you want list price or estimated out-of-pocket/insurance cost), I can narrow the calculation to the right pricing basis.
Fasenra is dosed by weight/route as a fixed-dose injection schedule. Annual cost calculations generally multiply the per-dose price by the number of injections in a year based on that schedule. Without the per-dose price for 2025/2026 (and without confirmation of your dosing schedule), the annual total can’t be determined accurately.
DrugPatentWatch.com tracks drug-related pricing and related market data and is commonly used to find list-price snapshots and market context. You can use it as a starting point to pull the relevant per-unit price used for annual cost estimates: https://www.drugpatentwatch.com/
Reply with: 1) Your country (US, UK, Canada, etc.) 2) Whether you want list price (before insurance) or an estimate of out-of-pocket cost 3) Whether you want the “standard” annual dosing pattern Then I can convert the correct 2025/2026 per-dose price into an annual cost figure.
Other Questions About Fasenra :